Questo sito utilizza cookie di terze parti per inviarti pubblicità in linea con le tue preferenze. Se vuoi saperne di più clicca QUI 
Chiudendo questo banner, scorrendo questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all'uso dei cookie. OK

Biological and transductional effects of allosteric antagonists on the activity of chemoattractant receptors

There are two major chemokine receptors expressed on the surface of neutrophils, CXCR1 and CXCR2.It is thought that targeting both receptors may be necessary for optimal inhibition of PMN influx in several inflammation disorders such as post-ischemia reperfusion injury, pulmonary fibrosis, sepsis, psoriasis among other.
DF 2156A is a potent dual inhibitor of CXCR1 and CXCR2 and was derived from a specific lead optimization program (Moriconi et al., 2007). Because it blocks both CXCR1 and CXCR2, it may overcome the problem of redundancy generated by the ELR+ CXC chemokine-CXCR1/R2 axis. The present study demonstrated, that DF 2156A is a potent blocker of both CXCR1 and CXCR2 expressed on PMNs, lymphocytes, and cells transfectants with a IC50 in the range of 1 to 2 nM. Despite its potency on both CXCL8 receptors, the effect of DF 2156A was highly specific. DF 2156A did not affect the activity of several related chemokine receptor belonging to both CC and CXC subfamilies. Our evidences show that DF 2156A is able to block different signaling pathway activated by CXCL8. Here we describe the molecular mechanism exerted by this compound. In particular it unaffected CXCL8- induced both receptors internalization but also both receptors recycling to the cell membrane after CXCL removal, indicating that it does not interfere more in general with the trafficking of both CXCL8 receptors. By contrats DF 2156A significantly suppressed CXCL8- induced cofilin phosphorylation and subsequent failure of CXCR1/R2 cells to migrate in response to CXCL8. Cofilin is protein that is postulated regulates cell migration and chemotaxis, in chemokine responses.
This model of concerted type of allosteric antagonists raises the possibility to stabilize slightly different active receptor conformations, which might interact preferentially with distinct tranducer molecules or signaling pathway. Moreover, this class of antagonists would offer untapped advantages for drug development programs.

Mostra/Nascondi contenuto.
8 1.INTRODUCTION 1.1 The chemokine system Over 40 chemokines have been identified to date 1 . Chemokines are produced by a variety of cell types either constituvely or in response to inflammatory stimuli, the biological activities of chemokines range from the control of leukocyte trafficking in basal and inflammatory conditions to regulation of hematopoiesis, angiogenesis, tissue architecture and organogenesis. The basis for such diversified activities rests, on one hand, upon the ubiquitous nature of chemokine production and chemokine receptor expression. Indeed virtually every cell type can produce chemokines and expresses a unique combination of chemokine receptors. On the other hand, chemokine receptors make use of a flexible and complex network of intracellular signaling machineries that can regulate a variety of cellular functions ranging from cell migration, growth, differentiation and death 2 . 1.2 Structure and biological function of chemokines Chemokines are small secreted proteins with the molecular weights in the range of 8- 12-KDa with 20 to 70 percent homology in amino acids sequences. They have been subdivided into families based on structural and genetic considerations; structurally they are similar, having at least three β-pleated sheets and a C-terminal α-helix, with disulfide bonds stabilizing overall topology (Figure 1) 1, 3 . Most chemokines have four characteristics cysteines (cys) in highly conserved positions and depending on the motif displayed by the first two cysteins, they have been classified into CXC or alpha (α)-chemokines, CC or beta (β), C or gamma (γ), and CX3C or delta (δ) chemokines classes 1, 3 . The only exception to the cysteins rule is lymphotactin, which has only two cysteins. In addition the CXC or alpha subfamily

Tesi di Dottorato

Dipartimento: Medicina Traslazionale

Autore: Nina Patricia Machado Torres Contatta »

Composta da 147 pagine.

 

Questa tesi ha raggiunto 15 click dal 26/06/2012.

Disponibile in PDF, la consultazione è esclusivamente in formato digitale.